Skip to main content
Premium Trial:

Request an Annual Quote

Alan Fletcher, Charles Blitzer

PerkinElmer announced this week that Alan Fletcher has joined the company as vice president of business development for its Life and Analytical Sciences business.
In this role, Fletcher will be responsible for growing the biodiscovery business by developing strategic partnerships and alliances in life sciences research, and by introducing new technologies for the GPCR, kinase, and biomarker drug target classes.
Prior to PerkinElmer, Fletcher held multiple positions in the science and discovery systems business units at GE Healthcare.

Znomics announced this week that Charles Blitzer has been named to its board of directors.
Prior to Znomics, Blitzer held a number of positions at Barbeau Pharma, Fulcrum Pharma, and MGI Pharma.
From 1989 to 1992, Blitzer was with Marion Merrill Dow, last serving as vice president of corporate development. At Marion Laboratories, from 1977 to 1989, he was vice president of licensing and business development; director of licensing; and general and patent counsel.

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.